Search
Spotlight
In-person and virtual events just for HCPs
In-person and virtual events just for HCPs
Specialty
View More
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
News
OncClub
All Oncology News
OncClub
All Oncology News
Media
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
Conferences
Conference Coverage
Conference Listing
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
Partners
Publications
Resources
Interactive Tools
Sponsored
Interactive Tools
Sponsored
Biomarker Consortium
Subscribe
Search
Spotlight
In-person and virtual events just for HCPs
Specialty
See All >
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Evolving Therapies in Chronic Lymphocytic Leukemia
EP. 1: Initial Work-up for Chronic Lymphocytic Leukemia
July 30th 2020
EP. 2: Impact of COVID-19 on Management of CLL
July 30th 2020
EP. 3: Advances in Frontline Therapy for CLL
July 30th 2020
EP. 4: Selecting First-Line Therapy for CLL
July 30th 2020
EP. 5: COVID-19 and CLL Treatment Initiation
July 30th 2020
EP. 6: Selecting Frontline Therapy for CLL
July 30th 2020
EP. 7: Frontline Treatment Options in CLL
July 30th 2020
EP. 8: Treating CLL During COVID-19
July 30th 2020
EP. 9: Current Role for Chemoimmunotherapy in CLL
July 30th 2020
EP. 10: BTK Inhibitors in CLL: Ibrutinib
July 30th 2020
EP. 11: Telemedicine for Patients With CLL
July 30th 2020
EP. 12: Therapies in the Pipeline for Frontline CLL
July 30th 2020
EP. 13: Second-Generation BTK Inhibitors in CLL
July 30th 2020
EP. 14: BTK inhibitor With vs Without a CD20-Targeted Antibody
July 30th 2020
EP. 15: Relapsed/Refractory CLL: Treatment Selection
July 30th 2020
EP. 16: Novel Therapies for Relapsed/Refractory CLL
July 30th 2020
EP. 17: Venetoclax and Obinutuzumab in CLL
July 30th 2020
EP. 18: Venetoclax Combinations, Safety and Efficacy
July 30th 2020
EP. 19: Utility of MRD Testing in CLL Management
July 30th 2020
EP. 20: MURANO Trial Update in R/R CLL
July 30th 2020
NEXT PAGE
<
1
2
>
PREVIOUS PAGE